Pharmacokinetics of zidovudine and lamivudine during oral uridine supplementation with NucleomaxX

J Acquir Immune Defic Syndr. 2008 May 1;48(1):114-6. doi: 10.1097/QAI.0b013e318160a67d.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Area Under Curve
  • Double-Blind Method
  • Female
  • HIV Infections / drug therapy
  • Humans
  • Lamivudine / administration & dosage
  • Lamivudine / pharmacokinetics*
  • Lamivudine / therapeutic use
  • Male
  • Placebos
  • Reverse Transcriptase Inhibitors / administration & dosage
  • Reverse Transcriptase Inhibitors / pharmacokinetics*
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Uridine / administration & dosage*
  • Zidovudine / administration & dosage
  • Zidovudine / pharmacokinetics*
  • Zidovudine / therapeutic use

Substances

  • Placebos
  • Reverse Transcriptase Inhibitors
  • Lamivudine
  • Zidovudine
  • Uridine